[Systemic enzyme therapy in chronic glomerulonephritis].
| Autor: | Siniachenko OV, Kovalenko VN, Mukhin IV, Ignatenko GA, Terzov AI |
|---|---|
| Jazyk: | ruština |
| Zdroj: | Terapevticheskii arkhiv [Ter Arkh] 2000; Vol. 72 (2), pp. 46-8. |
| Abstrakt: | Aim: To try polyenzyme drug vobenzim in chronic glomerulonephritis (CGN). Materials and Methods: 174 CGN patients were randomized into 2 groups. The study group of 39 patients received conventional pathogenetic treatment plus vobenzim (initial dose 18-24, maintenance 12-15 dragees a day). Control group of 135 patients were given only pathogenetic therapy. 67 patients appeared ineligible. Results: 3-6 months after the treatment the response was seen in 61.5% patients of the study and 17.8% patients of the control group. Side effects of vobenzim in CGN treatment were absent. Conclusion: Enzyme therapy with vobenzim in CGN is safe and effective. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|